Manufacturer of Controlled Substances; Notice of Application, 42418 [E6-11933]
Download as PDF
<![CDATA[
42418
Federal Register / Vol. 71, No. 143 / Wednesday, July 26, 2006 / Notices
should be addressed, in quintuplicate,
to the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative/ODL; or
any being sent via express mail should
be sent to DEA Headquarters, Attention:
DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than August 25, 2006.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e) and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745–46), all applicants for
registration to import a basic class of
any controlled substance listed in
Schedule I or II are, and will continue
to be required to demonstrate to the
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a), 21 U.S.C. 823(a), and 21
CFR 1301.34(b), (c), (d), (e) and (f) are
satisfied.
Dated: July 19, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–11932 Filed 7–25–06; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
sroberts on PROD1PC70 with NOTICES
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to section 1301.33(a) of Title
21 of the Code of Federal Regulations
(CFR), this is notice that on February 7,
2006, Polaroid Corporation, 1265 Main
Street, Building W6, Waltham,
Massachusetts 02454, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of 2,5Dimethoxyamphetamine (7396), a basic
class of controlled substance listed in
Schedule I.
The company plans to manufacture
the listed controlled substance in bulk
for conversion into non-controlled
substance.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
VerDate Aug<31>2005
17:16 Jul 25, 2006
Jkt 208001
Any such written comments or
objections being sent via regular mail
should be addressed, in quintuplicate,
to the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative/ODL; or
any being sent via express mail should
be sent to DEA Headquarters, Attention:
DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than September 25, 2006.
Dated: July 10, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–11933 Filed 7–25–06; 8:45 am]
BILLING CODE 4410–09–P
good.larry@dol.gov. Statements received
on or before August 3, 2006 will be
included in the record of the meeting.
Individuals or representatives of
organizations wishing to address the
Working Group should forward their
requests to the Executive Secretary or
telephone (202) 693–8668. Oral
presentations will be limited to 20
minutes, time permitting, but an
extended statement may be submitted
for the record. Individuals with
disabilities who need special
accommodations should contact Larry
Good by August 3, 2006 at the address
indicated.
Signed at Washington, DC, this 18th day of
July, 2006.
Ann L. Combs,
Assistant Secretary, Employee Benefits
Security Administration.
[FR Doc. 06–6522 Filed 7–25–06; 8:45 am]
BILLING CODE 4510–29–M
DEPARTMENT OF LABOR
Employee Benefits Security
Administration
DEPARTMENT OF LABOR
Advisory Council on Employee Welfare
and Pension Benefit Plans Working
Group on Health Information
Technology; Notice of Meeting
Pursuant to the authority contained in
Section 512 of the Employee Retirement
Income Security Act of 1974 (ERISA), 29
U.S.C. 1142, the Working Group
assigned by the Advisory Council on
Employee Welfare and Pension Benefit
Plans to study the issue of Health
Information Technology will hold an
open public meeting on August 10,
2006.
The session will take place in Room
N4437 A–C, U.S. Department of Labor,
200 Constitution Avenue, NW.,
Washington, DC 20210. The purpose of
the open meeting, which will run from
9:45 a.m. to approximately 5 p.m., with
a one hour break for lunch, is for
Working Group members to hear
testimony from invited witnesses. The
Working Group will study what is
necessary to encourage the widespread
adoption of health information
technology using common standards
and how the federal government can
work with the private sector and
industry to accomplish this objective.
Organizations or members of the
public wishing to submit a written
statement pertaining to the topic may do
so by submitting 25 copies on or before
August 3, 2006 to Larry Good, Executive
Secretary, ERISA Advisory Council,
U.S. Department of Labor, Suite N–
5623, 200 Constitution Avenue, NW.,
Washington, DC 20210. Statements also
may be submitted electronically to
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
Employee Benefits Security
Administration
Advisory Council on Employee Welfare
and Pension Benefit Plans Working
Group on Plan Asset Rules,
Exemptions, and Cross Trading;
Notice of Meeting
Pursuant to the authority contained in
Section 512 of the Employee Retirement
Income Security Act of 1974 (ERISA), 29
U.S.C. 1142, the Working Group
assigned by the Advisory Council on
Employee Welfare and Pension Benefit
Plans to study the issue of Plan Asset
Rules, Exemptions, and Cross Trading
will hold an open public meeting on
August 11, 2006.
The session will take place in Room
N4437 A–C, U.S. Department of Labor,
200 Constitution Avenue, NW.,
Washington, DC 20210. The purpose of
the open meeting, which will run from
9 a.m. to approximately 5 p.m., with a
one hour break for lunch, is for Working
Group members to hear testimony from
invited witnesses. The working group
will study (1) the current applicability
of the 1987 plan asset regulation, to
determine whether the regulation
should be modified or whether other
DOL action is appropriate to clarify the
existing regulation, and (2) cross
trading, to determine whether the DOL
should issue broader exemptive relief
for cross-trading.
Organizations or members of the
public wishing to submit a written
statement pertaining to the topic may do
so by submitting 25 copies on or before
August 3, 2006 to Larry Good, Executive
E:\FR\FM\26JYN1.SGM
26JYN1
]]>Agencies
[Federal Register Volume 71, Number 143 (Wednesday, July 26, 2006)]
[Notices]
[Page 42418]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-11933]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to section 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on February 7, 2006, Polaroid
Corporation, 1265 Main Street, Building W6, Waltham, Massachusetts
02454, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of 2,5-
Dimethoxyamphetamine (7396), a basic class of controlled substance
listed in Schedule I.
The company plans to manufacture the listed controlled substance in
bulk for conversion into non-controlled substance.
Any other such applicant and any person who is presently registered
with DEA to manufacture such a substance may file comments or
objections to the issuance of the proposed registration pursuant to 21
CFR 1301.33(a).
Any such written comments or objections being sent via regular mail
should be addressed, in quintuplicate, to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC 20537, Attention: DEA Federal Register
Representative/ODL; or any being sent via express mail should be sent
to DEA Headquarters, Attention: DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must
be filed no later than September 25, 2006.
Dated: July 10, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-11933 Filed 7-25-06; 8:45 am]
BILLING CODE 4410-09-P
